These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3818781)

  • 1. Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.
    Lellé RJ; Heidenreich W; Stauch G; Wecke I; Gerdes J
    J Cancer Res Clin Oncol; 1987; 113(1):73-7. PubMed ID: 3818781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
    Kunz J; Schmidt A
    Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.
    Meyer JS; Connor RE
    Cancer; 1982 Aug; 50(4):746-51. PubMed ID: 7093909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
    Gerdes J; Lelle RJ; Pickartz H; Heidenreich W; Schwarting R; Kurtsiefer L; Stauch G; Stein H
    J Clin Pathol; 1986 Sep; 39(9):977-80. PubMed ID: 3020096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of benign breast disease by fine needle aspiration cytology. Comparison of cytologic and histologic findings in 265 palpable breast masses.
    Maygarden SJ; Novotny DB; Johnson DE; Frable WJ
    Acta Cytol; 1994; 38(2):115-29. PubMed ID: 8147200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
    Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
    Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE; Miller AB
    Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
    Visscher DW; Frost MH; Hartmann LC; Frank RD; Vierkant RA; McCullough AE; Winham SJ; Vachon CM; Ghosh K; Brandt KR; Farrell AM; Tarabishy Y; Hieken TJ; Haddad TC; Kraft RA; Radisky DC; Degnim AC
    Cancer; 2016 Feb; 122(3):378-85. PubMed ID: 26512815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Small focal lesions of the breast: a clinico-morphological analysis].
    Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
    Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for breast cancer from benign breast disease in a diverse population.
    Worsham MJ; Raju U; Lu M; Kapke A; Botttrell A; Cheng J; Shah V; Savera A; Wolman SR
    Breast Cancer Res Treat; 2009 Nov; 118(1):1-7. PubMed ID: 18836828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group.
    McDivitt RW; Stevens JA; Lee NC; Wingo PA; Rubin GL; Gersell D
    Cancer; 1992 Mar; 69(6):1408-14. PubMed ID: 1540878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P
    Cancer; 1993 Jun; 71(12):3908-13. PubMed ID: 8508356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thermobiologic evaluation of benign and malignant breast diseases].
    Gautherie M; Haehnel P; Walter JP
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):22-8. PubMed ID: 2984083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunt duct adenosis: a separate entity from columnar cell lesions?
    de Boer M; van Diest PJ
    J Clin Pathol; 2022 Jan; 75(1):5-9. PubMed ID: 33858936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sclerosing adenosis and infiltrating epitheliosis of the breast. Radiohistopathologic correlations and differential diagnosis of carcinoma].
    Gardellin G; Perin B; Natale F; Pierazzoli F; Adamo R
    Radiol Med; 1989 Oct; 78(4):335-8. PubMed ID: 2687962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up.
    Krieger N; Hiatt RA
    Am J Epidemiol; 1992 Mar; 135(6):619-31. PubMed ID: 1580238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.